Axa S.A. cut its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) by 23.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 173,475 shares of the real estate investment trust’s stock after selling 54,500 shares during the quarter. Axa S.A. owned 0.08% of Sabra Health Care REIT worth $2,276,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently bought and sold shares of the company. Barclays PLC boosted its holdings in Sabra Health Care REIT by 2.6% during the 3rd quarter. Barclays PLC now owns 780,159 shares of the real estate investment trust’s stock valued at $10,235,000 after acquiring an additional 19,742 shares during the period. Mutual Advisors LLC purchased a new position in shares of Sabra Health Care REIT in the 3rd quarter valued at approximately $203,000. Phocas Financial Corp. lifted its stake in shares of Sabra Health Care REIT by 3.3% in the 3rd quarter. Phocas Financial Corp. now owns 530,578 shares of the real estate investment trust’s stock valued at $6,961,000 after purchasing an additional 16,956 shares during the period. Rockefeller Capital Management L.P. lifted its stake in shares of Sabra Health Care REIT by 1,220.5% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 194,857 shares of the real estate investment trust’s stock valued at $2,556,000 after purchasing an additional 180,101 shares during the period. Finally, Exchange Traded Concepts LLC purchased a new position in shares of Sabra Health Care REIT in the 3rd quarter valued at approximately $546,000. 87.20% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on SBRA shares. Bank of America cut Sabra Health Care REIT from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $15.00 to $13.00 in a research note on Monday, November 14th. JMP Securities cut Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a research note on Tuesday, December 13th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $14.50.
Sabra Health Care REIT Stock Performance
Sabra Health Care REIT Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 28th. Shareholders of record on Monday, February 13th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 9.84%. The ex-dividend date of this dividend is Friday, February 10th. Sabra Health Care REIT’s payout ratio is -352.93%.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Featured Articles
- Get a free copy of the StockNews.com research report on Sabra Health Care REIT (SBRA)
- MarketBeat Week in Review – 2/20 – 2/24
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.
